FDA 执法报告 D-0150-2027:Victory Medical Center Pharmacy 替尔泊肽/左卡尼汀因缺乏工艺控制被定 II 类召回
FDA drug enforcement D-0150-2027: Victory Medical Center Pharmacy — Lack of Processing Controls
FDA 执法报告 D-0150-2027 记录 Victory Medical Center Pharmacy(得州奥斯汀)的替尔泊肽/左卡尼汀 25/50mg/mL 3mL 多剂量瓶产品因缺乏工艺控制被定为 II 类召回。
该执法报告记录替尔泊肽/左卡尼汀产品因缺乏工艺控制被定为 II 类召回,可核对三个批号与分销州范围。
FDA 药品召回执法报告 — D-0150-2027
报告发布日期:2026-11-11。这是执法报告日期,不是召回启动日期。
范围:一条已分类的药品召回记录;event_id 可能归组多个产品。没有召回编号的未分类记录不在本数据流范围内。本记录不是新闻稿,也不是新的执法认定。
openFDA 数据集每周更新。报告状态不是实时召回状态,不得用于跟踪召回生命周期。以下其他日期保留其各自名称所表示的含义。
完整官方产品记录(包括 openFDA 统一标识符):
{
"address_1": "4303 Victory Dr",
"address_2": "",
"center_classification_date": "20261030",
"city": "Austin",
"classification": "Class II",
"code_info": "批号、有效期:批号 2053172,有效期至 10/24/2026;批号 2028876,有效期至 10/27/2026;批号 2060129,有效期至 11/3/2026",
"country": "United States",
"distribution_pattern": "CO, FL, TX",
"event_id": "100168",
"initial_firm_notification": "Letter",
"more_code_info": "",
"openfda": {},
"postal_code": "78704-7507",
"product_description": "TIRZEPATIDE/L-CARNITINE (MDV) 25/50MG/ML **3ML**,VMC,Victory Medical Center Pharmacy,德克萨斯州奥斯汀",
"product_quantity": "343 瓶",
"product_type": "Drugs",
"reason_for_recall": "缺乏工艺控制",
"recall_initiation_date": "20261019",
"recall_number": "D-0150-2027",
"recalling_firm": "Victory Medical Center Pharmacy",
"report_date": "20261111",
"state": "TX",
"status": "Ongoing",
"voluntary_mandated": "Voluntary: Firm initiated"
}
来源:openFDA 已分级药品召回执法报告 · api.fda.gov